Caricamento...
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
Despite its good initial response and significant survival benefit in patients with castration-resistant prostate cancer (CRPC), taxane therapy inevitably encounters drug resistance in all patients. Deep understandings of taxane resistant mechanisms can significantly facilitate the development of ne...
Salvato in:
| Pubblicato in: | Acta Pharm Sin B |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089846/ https://ncbi.nlm.nih.gov/pubmed/30109177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2018.04.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|